The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma

British Journal of Ophthalmology

Volumn 94, Issue 10, 2010, Pages 1307-1311

  Stankiewicz, Andrzej ^a   Wierzbowska, Joanna ^a   Siemia̧tkowska, Anna ^a   Fuksińska, Beata ^a   Robaszkiewicz, Jacek ^a   Zegadło, Arkadiusz ^a   Ehrlich, Rita ^b   Siesky, Brent ^b   Harris, Alon ^b  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; DORZOLAMIDE;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; EYE BLOOD FLOW; HEART RATE; HUMAN; INTRAOCULAR PRESSURE; MONOTHERAPY; MORNING DOSAGE; OPEN ANGLE GLAUCOMA; OPHTHALMIC ARTERY; OPTIC NERVE; PERFUSION PRESSURE; PRIORITY JOURNAL; RETINA ARTERY;

ADULT; AGED; AGED, 80 AND OVER; AMIDES; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; CLOPROSTENOL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HEMODYNAMICS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC ARTERY; OPHTHALMIC SOLUTIONS; ORBIT; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SULFONAMIDES; THIOPHENES;

EID: 77958519929     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.162859     Document Type: Article

References (29)

1. Osborne NN, Wood JP, Chidlow G, et al. Ganglion cell death in glaucoma: what do we really know? Br J Ophthalmol 1999;83:980-6.
2. Graham SL, Drance SM, Wijsman K. Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip. Ophthalmology 1995;102:61-9.
3. Harris A, Spaeth G, Wilson R, et al. Nocturnal ophthalmic arterial hemodynamics in primary open-angle glaucoma. J Glaucoma 1997;6:170-4.
4. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56. (Pubitemid 36401765)
5. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000;9:134-42. (Pubitemid 32441322)
6. Barkana Y, Anis S, Liebmann J, et al. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 2006;24:793-7. (Pubitemid 43877672)
7. Zeitz O, Galambos P, Wagenfeld L, et al. Glaucoma progression is associated with decreased blood flow velocities in the short posterior ciliary artery. Br J Ophthalmol 2006;90:1245-8. (Pubitemid 44621484)
8. Plange N, Kaup M, Arend O, et al. Asymmetric visual field loss and retrobulbar haemodynamics in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2006;244:978-83. (Pubitemid 44184503)
9. Quaranta L, Gandolfo F, Turano R, et al. Effects of topical hypotensive drugs on circadian IOP, blood pressure and calculated diastolic ocular perfusion pressure in patients with glaucoma. Invest Ophthalmol Vis Sci 2006;47:2917-23. (Pubitemid 351639767)
10. Orzalesi N, Rossetti L, Bottoli A. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology 2006;113:239-46.
11. Arend O, Harris A, Wolter P, et al. Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients. Acta Ophthalmol Scand 2003;81:474-9.
12. Arici KM, Topalkara A, Güler C. Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure. Int Ophthalmol 1998;22:37-42.
13. Maruyama K, Shirato S. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial. J Glaucoma 2006;15:341-5.
14. Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St Louis: CV Mosby Company, 1993.
15. Nakamoto K, Yasuda N. Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma. J Glaucoma 2007;16:352-7. (Pubitemid 46945531)
16. Dirks MS, Noecker RJ, Earl M, et al. A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Adv Ther 2006;23:385-94. (Pubitemid 44409544)
17. Konstas AG, Holló G, Irkec M, et al. Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study. Br J Ophthalmol 2007;91:757-60. (Pubitemid 46846646)
18. Parrish RK, Palmberg P, Sheu WP, et al. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003;135:688-703. (Pubitemid 36457976)
19. Orzalesi N, Rossetti L, Invernizzi T, et al. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2000;41:2566-73. (Pubitemid 30624384)
20. Konstas AG, Mikropoulos D, Kaltsos K, et al. 24-hour intraocular pressure control obtained with evening- versus morning-dosed travoprost in primary open-angle glaucoma. Ophthalmology 2006;13:446-50. (Pubitemid 43296987)
21. Zeitz O, Matthiessen ET, Wiermann A, et al. Ocular hemodynamics in normal tension glaucoma: effect of bimatoprost. Klin Monatsbl Augenheilkd 2004;221:550-4.
22. Siesky B, Harris A, Sines D, et al. A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma. J Ocul Pharmacol Ther 2006;22:353-61.
23. Harris A, Jonescu-Cuypers CP, Kagemann L, et al. Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma. Am J Ophthalmol 2001;132:490-5.
24. Harris A, Joos K, Kay M, et al. Acute IOP elevation with scleral suction: effects on retrobulbar haemodynamics. Br J Ophthalmol 1996;80:1055-9.
25. Hosking SL, Harris A, Chung HS, et al. Ocular haemodynamic responses to induced hypercapnia and hyperoxia in glaucoma. Br J Ophthalmol 2004;88:406-11.
26. Galassi F, Sodi A, Ucci F, et al. Ocular hemodynamics and glaucoma prognosis: a color Doppler imaging study. Arch Ophthalmol 2003;21:1711-15.
27. Strenn K, Menapace R, Rainer G, et al. Reproducibility and sensitivity of scanning laser Doppler flowmetry during graded changes in PO2. Br J Ophthalmol 1997;81:360-4.
28. Fuchsjäger-Mayrl G, Wally B, Rainer G, et al. Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension. Br J Ophthalmol 2005;89:1293-7.
29. Quaranta L, Miglior S, Floriani I, et al. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma. Invest Ophthalmol Vis Sci 2008;49:4226-31.